Group 1 - WSFS Financial reported quarterly earnings of $1.27 per share, exceeding the Zacks Consensus Estimate of $1.13 per share, and showing an increase from $1.08 per share a year ago, resulting in an earnings surprise of +12.39% [1] - The company posted revenues of $267.5 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.36%, and showing a slight increase from $266.05 million year-over-year [2] - WSFS has outperformed the market with a share price increase of about 9.5% since the beginning of the year, compared to the S&P 500's gain of 8.1% [3] Group 2 - The earnings outlook for WSFS is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend of estimate revisions for WSFS was favorable ahead of the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $1.13 on revenues of $262.8 million, and for the current fiscal year, it is $4.64 on revenues of $1.04 billion [7] Group 3 - The outlook for the Financial - Savings and Loan industry, where WSFS operates, is currently in the bottom 26% of over 250 Zacks industries, which may impact the stock's performance [8]

分组1 - SouthState reported quarterly earnings of $2.3 per share, exceeding the Zacks Consensus Estimate of $2 per share, and showing an increase from $1.79 per share a year ago, resulting in an earnings surprise of +15.00% [1] - The company achieved revenues of $664.77 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.96%, and up from $425.48 million year-over-year [2] - SouthState has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed the market, losing about 2.3% since the beginning of the year, while the S&P 500 has gained 8.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $2.05 on revenues of $652.67 million, and for the current fiscal year, it is $8.13 on revenues of $2.59 billion [7] 分组3 - The Zacks Industry Rank places Financial - Miscellaneous Services in the top 38% of over 250 Zacks industries, indicating that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] - The estimate revisions trend for SouthState was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6]

分组1 - HNI reported quarterly earnings of $1.11 per share, exceeding the Zacks Consensus Estimate of $0.86 per share, and up from $0.79 per share a year ago, representing an earnings surprise of +29.07% [1] - The company achieved revenues of $667.1 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.17%, and an increase from $623.7 million year-over-year [2] - HNI has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates twice in the same period [2] 分组2 - The stock has gained approximately 4.2% since the beginning of the year, while the S&P 500 has increased by 8.1% [3] - The current consensus EPS estimate for the upcoming quarter is $1.16 on revenues of $699.2 million, and for the current fiscal year, it is $3.50 on revenues of $2.64 billion [7] - The Business - Office Products industry, to which HNI belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Group 1: Earnings Performance - First Northwest Bancorp reported quarterly earnings of $0.42 per share, significantly exceeding the Zacks Consensus Estimate of $0.09 per share, representing an earnings surprise of +366.67% [1] - The company’s earnings for the same quarter last year were $0.16 per share, indicating a year-over-year increase [1] - Over the last four quarters, the company has surpassed consensus EPS estimates two times [2] Group 2: Revenue Analysis - First Northwest Bancorp posted revenues of $16.36 million for the quarter ended June 2025, which missed the Zacks Consensus Estimate by 0.83% and decreased from $21.6 million year-over-year [2] - The company has topped consensus revenue estimates only once over the last four quarters [2] Group 3: Stock Performance and Outlook - First Northwest Bancorp shares have declined approximately 24.7% since the beginning of the year, contrasting with the S&P 500's gain of 8.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $17.5 million, while for the current fiscal year, it is -$0.26 on revenues of $67.8 million [7] Group 4: Industry Context - The Zacks Industry Rank for Banks - West is currently in the top 29% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]

Core Viewpoint - Mobileye Global (MBLY) reported quarterly earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.11 per share, and showing an increase from $0.09 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was +18.18%, with the company having surpassed consensus EPS estimates three times over the last four quarters [2] - Mobileye's revenues for the quarter ended June 2025 were $506 million, surpassing the Zacks Consensus Estimate by 0.51%, and up from $439 million year-over-year [3] - The company has also topped consensus revenue estimates four times in the last four quarters [3] Stock Performance - Mobileye shares have declined approximately 19.2% since the beginning of the year, contrasting with the S&P 500's gain of 8.1% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.06 on revenues of $436.49 million, and for the current fiscal year, it is $0.32 on revenues of $1.84 billion [8] - The outlook for the automotive industry, where Mobileye operates, is currently in the top 39% of Zacks industries, suggesting a favorable environment for performance [9]

Company Performance - Visteon reported quarterly earnings of $2.39 per share, exceeding the Zacks Consensus Estimate of $2.04 per share, but down from $2.54 per share a year ago, representing an earnings surprise of +17.16% [1] - The company posted revenues of $969 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.10%, compared to $1.01 billion in revenues a year ago [2] - Visteon has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times over the same period [2] Stock Performance - Visteon shares have increased approximately 28.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 8.1% [3] - The current consensus EPS estimate for the upcoming quarter is $1.80 on revenues of $915.78 million, and for the current fiscal year, it is $7.78 on revenues of $3.67 billion [7] Industry Outlook - The Automotive - Original Equipment industry, to which Visteon belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Visteon's stock performance [5][6]

Group 1: Earnings Performance - Tractor Supply (TSCO) reported quarterly earnings of $0.81 per share, exceeding the Zacks Consensus Estimate of $0.80 per share, and up from $0.79 per share a year ago, representing an earnings surprise of +1.25% [1] - The company posted revenues of $4.44 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.87%, compared to year-ago revenues of $4.25 billion [2] Group 2: Stock Performance and Outlook - Tractor Supply shares have increased approximately 12.4% since the beginning of the year, outperforming the S&P 500's gain of 8.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] Group 3: Estimate Revisions and Industry Context - The trend for estimate revisions for Tractor Supply was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $0.47 on revenues of $3.72 billion, and for the current fiscal year, it is $2.09 on revenues of $15.63 billion [7] - The Retail - Miscellaneous industry, to which Tractor Supply belongs, is currently in the bottom 20% of the Zacks industries, suggesting potential challenges for stock performance [8]

Company Overview - Cartesian Therapeutics, Inc. (RNAC) shares increased by 9.9% to close at $13.39, with trading volume significantly higher than usual, reflecting strong investor interest [1] - The stock has gained 17.6% over the past four weeks, indicating a positive trend [1] Pipeline and Clinical Trials - The surge in stock price is attributed to positive investor expectations regarding the company's mRNA cell therapy pipeline for autoimmune diseases [2] - The lead candidate, Descartes-08, is currently in a phase III study for Myasthenia Gravis and is also being evaluated for systemic lupus erythematosus in a phase II study [2] - Another candidate, Descartes-15, is in early-stage studies for multiple myeloma, further diversifying the clinical-stage pipeline [2] Financial Performance Expectations - The company is expected to report a quarterly loss of $0.76 per share, a significant year-over-year decline of 240.7% [3] - Projected revenues for the upcoming quarter are $0.75 million, down 97.8% from the same quarter last year [3] Earnings Estimate Revisions - The consensus EPS estimate for the quarter has been revised 4.6% higher in the last 30 days, which is typically a positive indicator for future stock price appreciation [4] - A positive trend in earnings estimate revisions is correlated with potential price increases, suggesting that RNAC may continue to strengthen [4] Industry Context - Cartesian Therapeutics operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like DBV Technologies S.A. (DBVT) [4] - DBVT's stock closed 2% higher at $9.47, with an 8.9% return over the past month, indicating a favorable environment within the industry [4][5]

Textron (TXT) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.90%. A quarter ago, it was expected that this maker of Cessna small planes and Bell helicopters would post earnings of $1.17 per share when it actually produced earnings of $1.28, delivering a surprise of +9.4%.Over the ...

Company Performance - Gentherm reported quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.59 per share, and down from $0.66 per share a year ago, representing an earnings surprise of -8.47% [1] - The company posted revenues of $375.09 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.78%, but down from $375.68 million year-over-year [2] - Over the last four quarters, Gentherm has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Gentherm shares have lost about 19.9% since the beginning of the year, while the S&P 500 has gained 8.1% [3] - The current Zacks Rank for Gentherm is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $0.61 on revenues of $366.45 million, and for the current fiscal year, it is $2.21 on revenues of $1.43 billion [7] - The outlook for the automotive industry, where Gentherm operates, is currently in the top 39% of Zacks industries, suggesting a favorable environment for performance [8]